Search icon

MELBRAN DRUGS, INC.

Company Details

Name: MELBRAN DRUGS, INC.
Jurisdiction: New York
Legal type: DOMESTIC BUSINESS CORPORATION
Status: Active
Date of registration: 14 Oct 2004 (20 years ago)
Entity Number: 3113726
ZIP code: 10032
County: New York
Place of Formation: New York
Principal Address: 605 W 168TH ST, NEW YORK, NY, United States, 10032
Address: 605 WEST 168TH STREET, NEW YORK, NY, United States, 10032

Contact Details

Phone +1 212-568-1300

Shares Details

Shares issued 200

Share Par Value 0

Type NO PAR VALUE

form 5500

Plan Name Plan Year EIN/PN Received Sponsor Total number of participants
MELBRAN DRUGS INC PENSION PLAN 2023 061742100 2024-10-15 MELBRAN DRUGS INC 5
File View Page
Three-digit plan number (PN) 002
Effective date of plan 2020-01-01
Business code 446110
Sponsor’s telephone number 2125681300
Plan sponsor’s address 605 W. 168TH STREET, NEW YORK, NY, 10032
MELBRAN DRUGS INC 401K PROFIT SHARING PLAN 2023 061742100 2024-10-09 MELBRAN DRUGS INC 5
File View Page
Three-digit plan number (PN) 001
Effective date of plan 2020-01-01
Business code 446110
Sponsor’s telephone number 2125681300
Plan sponsor’s address 605 W. 168TH STREET, NEW YORK, NY, 10032
MELBRAN DRUGS INC PENSION PLAN 2022 061742100 2023-10-15 MELBRAN DRUGS INC 5
File View Page
Three-digit plan number (PN) 002
Effective date of plan 2020-01-01
Business code 446110
Sponsor’s telephone number 2125681300
Plan sponsor’s address 605 W. 168TH STREET, NEW YORK, NY, 10032
MELBRAN DRUGS INC 401K PROFIT SHARING PLAN 2022 061742100 2023-10-15 MELBRAN DRUGS INC 5
File View Page
Three-digit plan number (PN) 001
Effective date of plan 2020-01-01
Business code 446110
Sponsor’s telephone number 2125681300
Plan sponsor’s address 605 W. 168TH STREET, NEW YORK, NY, 10032
MELBRAN DRUGS INC 401K PROFIT SHARING PLAN 2021 061742100 2022-10-17 MELBRAN DRUGS INC 4
File View Page
Three-digit plan number (PN) 001
Effective date of plan 2020-01-01
Business code 446110
Sponsor’s telephone number 2125681300
Plan sponsor’s address 605 W. 168TH STREET, NEW YORK, NY, 10032
MELBRAN DRUGS INC PENSION PLAN 2021 061742100 2022-10-17 MELBRAN DRUGS INC 4
File View Page
Three-digit plan number (PN) 002
Effective date of plan 2020-01-01
Business code 446110
Sponsor’s telephone number 2125681300
Plan sponsor’s address 605 W. 168TH STREET, NEW YORK, NY, 10032
MELBRAN DRUGS INC PENSION PLAN 2020 061742100 2021-10-11 MELBRAN DRUGS INC 4
File View Page
Three-digit plan number (PN) 002
Effective date of plan 2020-01-01
Business code 446110
Sponsor’s telephone number 2125681300
Plan sponsor’s address 605 W. 168TH STREET, NEW YORK, NY, 10032
MELBRAN DRUGS INC 401K PROFIT SHARING PLAN 2020 061742100 2021-10-11 MELBRAN DRUGS INC 3
File View Page
Three-digit plan number (PN) 001
Effective date of plan 2020-01-01
Business code 446110
Sponsor’s telephone number 2125681300
Plan sponsor’s address 605 W. 168TH STREET, NEW YORK, NY, 10032

Chief Executive Officer

Name Role Address
A KUMAR SURANENI Chief Executive Officer 605 W 168TH ST, NEW YORK, NY, United States, 10032

DOS Process Agent

Name Role Address
MELBRAN DRUGS, INC. DOS Process Agent 605 WEST 168TH STREET, NEW YORK, NY, United States, 10032

History

Start date End date Type Value
2006-10-19 2008-11-03 Address 605 W 168TH ST, NEW YORK, NY, 10022, USA (Type of address: Chief Executive Officer)
2006-10-19 2008-11-03 Address 605 W 168TH ST, NEW YORK, NY, 10022, USA (Type of address: Principal Executive Office)
2004-10-14 2020-10-02 Address 605 WEST 168TH STREET, NEW YORK, NY, 10032, USA (Type of address: Service of Process)

Filings

Filing Number Date Filed Type Effective Date
201002060842 2020-10-02 BIENNIAL STATEMENT 2020-10-01
181001008001 2018-10-01 BIENNIAL STATEMENT 2018-10-01
141208007583 2014-12-08 BIENNIAL STATEMENT 2014-10-01
121102002536 2012-11-02 BIENNIAL STATEMENT 2012-10-01
110301002841 2011-03-01 BIENNIAL STATEMENT 2010-10-01
081103002493 2008-11-03 BIENNIAL STATEMENT 2008-10-01
061019002191 2006-10-19 BIENNIAL STATEMENT 2006-10-01
041014000522 2004-10-14 CERTIFICATE OF INCORPORATION 2004-10-14

Date of last update: 01 Jan 2025

Sources: New York Secretary of State